2 Monster Energy Stocks to Hold for the Next 10 Years

NextEra Energy’s proposed $67 billion all-stock merger with Dominion Energy would create a utility giant with 110 GW in operation, a 130 GW project pipeline, and 51 GW of contracted data center capacity. Chevron has already closed its Hess acquisition, adding exposure to the Stabroek Block in Guyana and supporting management’s target for 2% to 3% annual production growth and 10% annualized earnings/cash flow growth through 2030. The article is broadly constructive on both names, though Chevron’s near-term performance is also tied to elevated energy prices and geopolitical risk.

Analysis

This is really a story about regulated scarcity becoming more valuable, not just bigger balance sheets. If AI/data-center load growth keeps tightening the power market, the winners are the utilities and generators with transmission, interconnection queues, and contracted load already in hand; the losers are late-cycle developers who still need land, permits, and grid access. That favors NEE on a multi-year view, but the upside is increasingly tied to execution on a very large integration and financing event, so the market may be underpricing the operational complexity.

The more interesting second-order effect is that Dominion’s data-center backlog makes the combined utility less of a pure defensive yield vehicle and more of a quasi-infrastructure growth asset. That can support a valuation rerate if load growth translates into faster rate base expansion, but it also raises the probability of political scrutiny if customer bills rise faster than local wage growth. In other words, the catalyst is not just approval; it’s whether regulators allow the company to monetize scarcity without a backlash over affordability.

For Chevron, the market is likely treating the Hess asset as a clean earnings step-up, but the real edge is duration: Guyana plus the existing global portfolio should improve reserve replacement and flatten the production profile, which matters more than near-term oil price noise. The stock can work even if crude cools, but the beta to geopolitics is now more two-sided — any de-escalation in the Middle East could compress sentiment and force the market to re-underwrite the equity on a lower price deck. That makes the current setup attractive for income, but less attractive for momentum buyers chasing the war premium.

The consensus seems to be underestimating how quickly the market can rotate from "scarcity beneficiary" to "policy target" in utilities, and from "geopolitical hedge" to "cash-flow machine" in integrated oils. The best risk/reward is not outright chasing both names equally; it is owning the one with secular load growth and hedging the one most exposed to a normalization in crude. Over 6-18 months, the bigger surprise is likely NEE if the merger clears and the data-center narrative gets rate-base treatment, while CVX is the steadier compounder but with more headline beta to oil.

Key Decisions for Investors

• Long NEE into merger-regulatory milestones over the next 6-12 months; upside improves if approval paths remain intact and the market starts capitalizing data-center backlog as quasi-contracted utility growth. Risk: rate/regulatory pushback or integration discount widening.
• Sell CVX upside against the current geopolitical premium: consider a 3-6 month covered-call overwrite or call spread to monetize elevated implied/realized volatility. Best if crude mean-reverts while the long-term thesis stays intact.
• Pair trade: long NEE / short a basket of smaller regulated utilities over 6-12 months. The thesis is that scarce power growth and data-center exposure will continue to reward scale, while smaller peers face higher financing costs and less visible load optionality.
• If seeking energy beta, prefer CVX over pure E&Ps on a 12-month horizon; the integrated downstream and dividend support reduce drawdown risk if oil falls back toward incentive prices. Use pullbacks toward the low-multiple range as entry, but avoid chasing after war-driven spikes.
• Hedge the NEE thesis with short-dated put spreads around regulatory decision dates. The risk/reward is favorable because the stock can rerate on approval, but any delay or adverse conditions could compress the multiple quickly.